-
公开(公告)号:US20200165347A1
公开(公告)日:2020-05-28
申请号:US16625902
申请日:2018-06-29
发明人: Bertil Lindmark , Ann Gee Lisa Ooi
摘要: The present disclosure provides a method of treating cutaneous T cell lymphoma (CTCL), in particular mycosis fungoides and/or Sézary syndrome, comprising administering a therapeutically effective amount of an antagonist antibody or binding fragment thereof specific to the IL-13 receptor to a patient in need thereof.
-
公开(公告)号:US20190151326A1
公开(公告)日:2019-05-23
申请号:US16252452
申请日:2019-01-18
发明人: Bertil Lindmark , Ann Gee Lisa Ooi
IPC分类号: A61K31/5377 , A61P35/02 , A61K31/517 , A61K31/4545 , A61K31/075 , A61K31/502 , A61K31/201 , A61K31/4745
摘要: A method of treating haematological cancer with a therapy comprising a DHODH inhibitor. Also provided is a combination therapy comprising a pan-HER inhibitor and a DHODH inhibitor for treating a haematological cancer.
-
公开(公告)号:US11382903B2
公开(公告)日:2022-07-12
申请号:US16154422
申请日:2018-10-08
IPC分类号: A61K31/4418 , A61P35/02 , A61K31/505 , A61K45/06 , A61K31/075 , A61K31/4545 , A61K31/502 , A61K31/517 , A61K31/553
摘要: A method of treating haematological cancer with a therapy comprising a DHODH inhibitor. Also provided is a combination therapy comprising a pan-HER inhibitor and a DHODH inhibitor for treating a haematological cancer.
-
公开(公告)号:US11311548B2
公开(公告)日:2022-04-26
申请号:US16252452
申请日:2019-01-18
IPC分类号: A61K31/5377 , A61P35/02 , A61K31/517 , A61K31/4545 , A61K31/075 , A61K31/201 , A61K31/4745 , A61K31/502 , A61K31/704 , A61K31/164 , A61K31/4995
摘要: A method of treating haematological cancer with a therapy comprising a DHODH inhibitor. Also provided is a combination therapy comprising a pan-HER inhibitor and a DHODH inhibitor for treating a haematological cancer.
-
公开(公告)号:US20190038610A1
公开(公告)日:2019-02-07
申请号:US16154422
申请日:2018-10-08
发明人: Bertil Lindmark , Ann Gee Lisa Ooi
IPC分类号: A61K31/4418 , A61P35/02
摘要: A method of treating haematological cancer with a therapy comprising a DHODH inhibitor. Also provided is a combination therapy comprising a pan-HER inhibitor and a DHODH inhibitor for treating a haematological cancer.
-
-
-
-